Found 753 All Conditions trials
A listing of All Conditions medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.
A three-year, multi-center, double-blind, extension study to evaluate the long-term safety and efficacy of ligelizumab in patients who completed ligelizumab's Phase III studies in food allergy.
K
Kirsten Kloepfer, MD
Phase 3
What is this study about?This is an extension study to evaluate the long-term safety and efficacy of ligelizumab in participants who have completed a ligelizumab Phase III study in food allergy.THIS STUDY IS ENROLLING BY INVITATION ONLY - the research team will directly contact participants who have completed the treatment …
Dual-Site Stimulation for OSA (BOOST Study)
N
Noah Parker, MD
What is this study about?The objective of this early feasibility study is to assess the safety of chronic dual site stimulation by adding infrahyoid stimulation in non-responding patients with pre-existing single-site hypoglossal nerve stimulation.This study will also assess whether the secondary Inspire System can achieve the intended purpose of causing …
Crohn's Disease: Pharmacokinetics, Efficacy, and Safety of Risankizumab in Pediatric Subjects with Moderately to Severely Active Crohn's Disease
T
Tina Zhang
What is this study about?The objective of this study is to assess the pharmacokinetics (PK), efficacy, and safety of risankizumab in pediatric subjects with moderately to severely active CD aged 2 to < 18 years old who have had intolerance or inadequate response to aminosalicylates, oral locally acting corticosteroids, systemic …
Pilot RCT of Self-stigma Treatment for First Episode Psychosis (NECT-YA)
B
Bethany Leonhardt
What is the purpose of this study?The purpose of this study is to conduct preliminary testing of a group psychotherapy invention (Narrative Enhancement and Cognitive Therapy; NECT). This intervention targets self-stigma and illness conceptions among persons with first-epiosde psychosis with the goal of increasing treatment engagement. THIS STUDY IS ENROLLING …
Non-Invasive Quantification of Liver Health in NASH (N-QUAN)
R
Raj Vuppalanchi, MD
To evaluate, in patients with suspected NASH referred for liver biopsy, the diagnosticCT1 at discriminating those with NAS≥4 & F≥2 from those without.
HEALEY ALS Platform: Multi-Center, Multi-Regimen clinical trial evaluating investigational products for the treatment of ALS
C
Cynthia Bodkin, MD
ALS is a degenerative disorder of the nerves controlling movement (“motor neurons”). ALS causes muscles to become weak, which leads to paralysis. ALS is a condition that gradually damages the nerve cells in the brain and spinal cord. Currently, there are no treatments to prevent, reverse, or stop the development of …
HAVE YOU RECENTLY TESTED POSITIVE FOR COVID? Help Us Test a New Treatment for Covid!
J
James Chmiel
M
Mike Davis
Researchers at Indiana University School of Medicine are researching a nasal treatment for COVID-19. We are looking for people with a recent onset of mild COVID-19 symptoms and a positive COVID-19 test in the last few days to come for a 2 hour visit at Riley Hospital for Children to help …
Improving Lung Cancer Screening Rates
F
Francesca Duncan
Lung cancer is the leading cause of cancer death in the United States among men and women. Lung cancer screening using low-dose CT scan can identify lung cancer at its’ earliest stage when more curative treatment options are available. However, only 4-6% of people eligible for lung cancer screening get …
A randomized, double-blind, dose-ranging, placebo-controlled study to evaluate the efficacy and safety of PLN-74809 (bexotegrast) for the treatment of idiopathic pulmonary fibrosis (BEACON)
R
Ryan Boente
What is this study about?To characterize the effect of bexotrgrast versus placebo on the change in forced vital capacity (FVC) in participants with idiopathic pulmonarybrosis (IPF) at Week 52.
A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation (LIBREXIA-AF)
J
John Strobel, MD
Phase 3
The purpose of this study is to evaluate if milvexian is at least as effective as apixabanducing the risk of the composite stroke and non- central nervous system (CNS) systemicbolism.
